News Sentiment

NMTC sentiment intelligence

Neuroone Medical Technologies Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 2.88 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 64

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-4.0% over one week, -11.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -4.0% Price reacting lower
Trend fit Trend inactive -11.1% over four weeks
Fair value -47.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 44
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 64
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
Stock Titan 8
NewMediaWire 5
TradingKey 5
dars.gov.et 2
StockStory 2
GuruFocus.com 2
Investing.com Nigeria 1

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 25
Analyst action 2
Macro sensitivity 2
Deals and strategy 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 64
Finviz Direct company coverage

NMTC - NeuroOne Medical Technologies Corp Stock Price and Quote

This article provides a comprehensive overview of NeuroOne Medical Technologies Corp (NMTC), including its stock price, financial metrics, analyst ratings, performance history, and recent news. It highlights the company's inclusion in the Russell Microcap Index and details signif

Tone
Negative 34/100
Event
Analyst action
Published
30 May 2026 15:09
Source
Finviz
Quantisnow Direct company coverage

NMTC - NeuroOne Medical Technologies Corporation stock news, filings & ratings

NeuroOne Medical Technologies Corporation (NMTC) operates as a medical technology company specializing in thin-film electrode technology for various neurological disorders. The company's stock is currently trading at $3.55, down 4.70%, and it has recently seen several SEC filings

Tone
Neutral 50/100
Event
Market update
Published
30 May 2026 01:09
Source
Quantisnow
Minichart Direct company coverage

NeuroOne Medical Technologies to Restate Q1 2026 Financials After Revenue Overstatement; Reaffirms $10.5M FY2026 Guidance

NeuroOne Medical Technologies will restate its Q1 2026 financial results due to a revenue recognition error that caused a $0.5 million overstatement. The restatement will impact gross profit and net loss figures for the quarter. Despite this, the company reaffirms its fiscal year

Tone
Neutral 50/100
Event
Earnings
Published
23 May 2026 11:41
Source
Minichart
Bitget Direct company coverage

According to documents submitted by NEUROONE MEDICAL TECH to the U.S. Securities and Exchange Commission, the company has restated its financial data for the first quarter of 2026 to correct a previous overstatement of revenue by approximately $50

NEUROONE MEDICAL TECH has restated its financial data for the first quarter of 2026, correcting an overstatement of revenue by approximately $500,000. This action, submitted to the U.S. Securities and Exchange Commission, aims to ensure accuracy and compliance. Investors are advi

Tone
Negative 34/100
Event
Earnings
Published
22 May 2026 21:39
Source
Bitget
Stock Titan Direct company coverage

NeuroOne (Nasdaq: NMTC) to restate March 31 2026 results, keeps guidance

NeuroOne Medical Technologies (Nasdaq: NMTC) announced it will restate its interim financial statements for the quarter ended March 31, 2026, due to revenue-recognition errors related to modified customer purchase orders. The company identified an overstatement of revenue by appr

Tone
Negative 38/100
Event
Earnings
Published
22 May 2026 20:12
Source
Stock Titan
Investing.com South Africa Direct company coverage

Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises By Investing.com

NeuroOne Medical Technologies Corporation reported Q2 FY2026 earnings per share and revenue below analyst forecasts, with an EPS of -$0.25 against -$0.22 expected and revenue of $2.4 million versus $2.58 million. Despite these misses, the company's stock rose by 4.16% due to stro

Tone
Neutral 50/100
Event
Earnings
Published
18 May 2026 20:40
Source
Investing.com South Africa